Abstract:BACKGROUND:Genome-wide association studies (GWAS) have successfully identified genetic susceptible variants for complex diseases. However, the underlying mechanism of such association remains largely unknown. Most disease-associated genetic variants have been shown to reside in noncoding regions, leading to the hypothesis that regulation of gene expression may be the primary biological mechanism. Current methods to characterize gene expression mediating the effect of genetic variant on diseases, often analyzed one gene at a time and ignored the network structure. The impact of genetic variant can propagate to other genes along the links in the network, then to the final disease. There could be multiple pathways from the genetic variant to the final disease, with each having the chain structure since the first node is one specific SNP (Single Nucleotide Polymorphism) variant and the end is disease outcome. One key but inadequately addressed question is how to measure the between-node connection strength and rank the effects of such chain-type pathways, which can provide statistical evidence to give the priority of some pathways for potential drug development in a cost-effective manner.RESULTS:We first introduce the maximal correlation coefficient (MCC) to represent the between-node connection, and then integrate MCC with K shortest paths algorithm to rank and identify the potential pathways from genetic variant to disease. The pathway importance score (PIS) was further provided to quantify the importance of each pathway. We termed this method as "MCC-SP". Various simulations are conducted to illustrate MCC is a better measurement of the between-node connection strength than other quantities including Pearson correlation, Spearman correlation, distance correlation, mutual information, and maximal information coefficient. Finally, we applied MCC-SP to analyze one real dataset from the Religious Orders Study and the Memory and Aging Project, and successfully detected 2 typical pathways from APOE genotype to Alzheimer's disease (AD) through gene expression enriched in Alzheimer's disease pathway.CONCLUSIONS:MCC-SP has powerful and robust performance in identifying the pathway(s) from the genetic variant to the disease. The source code of MCC-SP is freely available at GitHub ( https://github.com/zhuyuchen95/ADnet ).

Exploring the genetic patterns of complex diseases via the integrative genome-wide approach

MCC-SP: a Powerful Integration Method for Identification of Causal Pathways from Genetic Variants to Complex Disease.

Integrative functional linear model for genome-wide association studies with multiple traits

Genome-wide interaction-based association analysis identified multiple new susceptibility Loci for common diseases.

Searching Genome-Wide Multi-Locus Associations for Multiple Diseases Based on Bayesian Inference.

IGESS: a Statistical Approach to Integrating Individual-Level Genotype Data and Summary Statistics in Genome-Wide Association Studies.

Current Status of Studies on Genome-Wide Gene-Gene Interactions

Identifying Disease Related Sub-Pathways for Analysis of Genome-Wide Association Studies

A framework to decipher the genetic architecture of combinations of complex diseases: applications in cardiovascular medicine

Integrating Embeddings of Multiple Gene Networks to Prioritize Complex Disease-Associated Genes

Sharing of Genes and Pathways Across Complex Phenotypes: A Multilevel Genome-Wide Analysis.

Improving genetic risk prediction by leveraging pleiotropy

Integrated analysis of variants and pathways in genome-wide association studies using polygenic models of disease

Beyond guilty by association at scale: searching for causal variants on the basis of genome-wide summary statistics

Identification of Genes for Complex Diseases by Integrating Multiple Types of Genomic Data

Identifying Disease Associations Via Genome-Wide Association Studies

LPG: a four-groups probabilistic approach to leveraging pleiotropy in genome-wide association studies

GPA: A Statistical Approach to Prioritizing GWAS Results by Integrating Pleiotropy and Annotation

GPA: A statistical approach to prioritizing GWAS results by integrating pleiotropy information and annotation data

LLR: a Latent Low-Rank Approach to Colocalizing Genetic Risk Variants in Multiple GWAS.

Coupled mixed model for joint genetic analysis of complex disorders with two independently collected data sets